功能脂质组学:棕榈酸通过调节膜流动性和葡萄糖代谢抑制肝细胞癌发展
研究对多种肝细胞癌细胞进行脂质组学分析,鉴定出1700余种完整脂质,发现含棕榈酰(C16:0)的甘油磷脂减少与转移能力正相关。体外和体内实验显示C16:0孵育可抑制恶性细胞增殖、侵袭和鼠异种移植瘤生长,机制涉及降低膜流动性、限制葡萄糖代谢及减弱mTOR和STAT3通路磷酸化。临床标本分析显示10种改变脂质中8种含C16:0脂质在癌组织较癌旁非肿瘤组织降低(P < 0.05)。
要点
- 肝细胞癌细胞中93种脂质显著改变,含C16:0甘油磷脂减少与转移能力正相关。
- C16:0孵育在体外和体内均抑制肝细胞癌增殖、侵袭和异种移植瘤生长。
- C16:0降低细胞膜流动性、限制葡萄糖代谢并减弱mTOR和STAT3通路磷酸化。
核心结论
- 改变脂质代谢有潜力作为癌细胞诊断标志物,靶向改变的C16:0代谢为治疗侵袭性肝细胞癌提供机会。
研究设计与样本
- 对一系列肝细胞癌细胞进行脂质组学分析,鉴定出来自三大脂质类别的1700余种完整脂质。
- 采用体外和体内实验(包括小鼠异种移植模型)验证C16:0孵育对恶性细胞增殖、侵袭和肿瘤生长的影响。
- 利用磷酸蛋白质组学方法检测C16:0孵育对mTOR和STAT3通路蛋白磷酸化水平的影响。
- 对443种脂质分子进行多反应监测分析,在一组临床肝细胞癌标本中比较癌组织与癌旁非肿瘤组织。
主要发现
- 比较脂质组学筛查显示93种脂质显著改变,含棕榈酰(C16:0)甘油磷脂减少与肝细胞癌细胞转移能力正相关。
- 体外和体内实验均表明C16:0孵育特异性降低恶性细胞增殖、削弱细胞侵袭性并抑制小鼠异种移植模型中的肿瘤生长。
- 生化实验表明C16:0处理降低细胞膜流动性并限制葡萄糖代谢。
- 磷酸蛋白质组学显示C16:0孵育减弱哺乳动物雷帕霉素靶蛋白(mTOR)和信号转导与转录激活因子3(STAT3)通路蛋白的磷酸化水平。
- 对443种脂质分子的多反应监测分析显示,在一组临床肝细胞癌标本中,癌组织与癌旁非肿瘤组织比较,10种改变脂质中8种含C16:0脂质降低(P < 0.05)。
关键数值与推荐
- 脂质组学分析鉴定出超过1700种完整脂质,来自三大脂质类别。
- 比较脂质组学筛查发现93种显著改变的脂质。
- 多反应监测分析443种脂质分子,临床肝细胞癌标本中癌组织较癌旁非肿瘤组织有10种脂质改变,其中8种含C16:0脂质降低(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Lipids are essential cellular components and energy sources of living organisms, and altered lipid composition is increasingly recognized as a signature of cancer. We performed lipidomic analysis in a series of hepatocellular carcinoma (HCC) cells and identified over 1,700 intact lipids originating from three major lipid categories. Comparative lipidomic screening revealed that 93 significantly changed lipids and decreased palmitic acyl (C16:0)-containing glycerophospholipids were positively associated with metastatic abilities of HCC cells. Furthermore, both in vitro and in vivo experiments demonstrated that C16:0 incubation specifically reduced malignant cell proliferation, impaired cell invasiveness, and suppressed tumor growth in mouse xenograft models. Biochemical experiments demonstrated that C16:0 treatment decreased cell membrane fluidity and limited glucose metabolism. A phosphoproteomics approach further revealed such C16:0 incubation attenuated phosphorylation levels of mammalian target of rapamycin (mTOR) and signal transducer and activator of transcription 3 (STAT3) pathway proteins. Multiple reaction monitoring analysis of 443 lipid molecules showed 8 reduced C16:0-containing lipids out of total 10 altered lipids when cancer tissues were compared with adjacent nontumor tissues in a cohort of clinical HCC specimens (P < 0.05). CONCLUSION: These data collectively demonstrate the biomedical potential of using altered lipid metabolism as a diagnostic marker for cancerous cells and open an opportunity for treating aggressive HCCs by targeting altered C16:0 metabolism. (Hepatology 2017;66:432-448).
引用
- Lin L, Ding Y, Wang Y, et al. Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism. Hepatology. 2017. PMID: 28073184. doi:10.1002/hep.29033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。